论文部分内容阅读
目的从文献计量学的角度反映了10年来耐多药结核研究的发展状况。方法利用SCIweb引文数据库检索1999—2008年间耐多药结核的文献,分别从耐多药结核研究的国家、机构和作者的发文量、被引频次和耐多药结核研究领域期刊分布情况及耐多药结核研究的学科主题等进行统计分析。结果统计范围内共有1 521篇文献,分布于337种期刊,近5年来文献逐年增多。WHO、美国、比利时等在该领域的研究影响力比较大。耐多药结核病的研究主要集中在传染病学、呼吸系统疾病、微生物病原学、药物学等学科领域。结论由于耐多药结核病的流行对全球公共卫生安全产生重大威胁,耐多药结核病的研究逐渐引起各国的重视,中国作为耐多药结核病的高负担国家还有待提高对此项研究的投入和研究水平。
Objective To reflect the development of MDR-TB research in the past decade from the perspective of bibliometrics. METHODS: The literature of MDR-TB was retrieved from the SCIweb Citation Database from 1999 to 2008. From the literature of countries, institutions and authors involved in MDR-TB research, the frequency of citation and the distribution of periodicals in the field of MDR-TB, Drug TB research subjects such as statistical analysis. Results A total of 1 521 articles were collected in the statistical range, distributed in 337 journals, and the literature has been increasing year by year in the past five years. WHO, the United States, Belgium and other research in this area more influential. Multidrug-resistant tuberculosis research focuses on infectious diseases, respiratory diseases, microbial etiology, pharmacology and other disciplines. Conclusions As the prevalence of multi-drug resistant tuberculosis poses a significant threat to global public health safety, the study of multidrug-resistant tuberculosis gradually attracts the attention of all countries. As a high-burden country with multi-drug resistant tuberculosis, China still needs to improve its input and research on this research Level.